Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus a Combination of Tapentadol PR and Pregabalin in Subjects With Severe Chronic Low Back Pain With a Neuropathic Pain Component

NCT01352741 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT01352741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01352741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus a Combination of Tapentadol PR and Pregabalin in Subjects With Severe Chronic Low Back Pain With a Neuropathic Pain Component
Lead sponsor
Grünenthal GmbH
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
January 31, 2012
Enrollment
622 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain, neuropathic pain